Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions.
Dietary exposure to the common foodborne mycotoxin deoxynivalenol (DON) selectively upregulates serum immunoglobulin A (IgA) in the mouse, most of which is polymeric, thus suggesting that the mucosal immune system is a primary target. When ingested, DON has no adjuvant or antigen properties but, rather, induces polyclonal IgA synthesis and serum elevation in an isotype-specific fashion. Resultant hyperelevated IgA is polyspecific, autoreactive and is likely to be involved in immune complex formation as well as kidney mesangial deposition. These latter effects mimic IgA nephropathy, the most common human glomerulonephritis. At the cellular level, DON upregulates production of T helper cytokines and enhances T cell help for IgA secretion. Analogous effects are observed in the macrophage with IL-6 being of particular importance based on ex vivo reconstitution and antibody ablation studies as well as experiments with IL-6 deficient mice. Upregulation of cytokines by DON involves both increased transcriptional activation and mRNA stability which are mediated by activation of mitogen-activated protein kinases. Interestingly, dietary omega-3 fatty acids can downregulate these processes and ameliorate DON-induced IgA nephropathy. From the perspective of gut mucosal immunotoxicology, these studies demonstrate that the capacity of a chemical to affect mucosal immune response can have systemic repercussions and, further, that these effects can be modulated by an appropriate nutritional intervention.
Pestka
James J
JJ
Department of Food Science and Human Nutrition, Institute for Environmental Toxicology, Michigan State University, 234 G.M. Trout Food Science and Human Nutrition Building, East Lansing, MI 48824-1224, USA. pestka@msu.edu
D000818:Animals; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology; D005922:Glomerulonephritis, IGA / Q000139:chemically induced* / Q000276:immunology; D007070:Immunoglobulin A / Q000096:biosynthesis*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D051379:Mice; D020929:Mitogen-Activated Protein Kinase Kinases / Q000187:drug effects* / Q000378:metabolism; D010581:Peyer's Patches / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D014255:Trichothecenes / Q000037:antagonists & inhibitors / Q000633:toxicity*
D015525:Fatty Acids, Omega-3; D007070:Immunoglobulin A; D014255:Trichothecenes; D020929:Mitogen-Activated Protein Kinase Kinases; C007262:deoxynivalenol